Podcasts about Journal club

Get access to more than 200 episodes of my premium podcast (The Aliquot) when you sign up as a FoundMyFitness Premium Member Download my "How to Train According to the Experts" guide One minute of vigorous exercise may be worth up to ten minutes of "moderate" cardio for extending lifespan and preventing chronic disease. In this Journal Club episode, Rhonda Patrick, PhD and endurance athlete Brady Holmer dissect a new Nature Communications study of more than 70,000 adults showing that vigorous intensity is roughly 4–10x more potent than moderate activity for reducing all-cause mortality, cardiovascular events, type 2 diabetes, and cancer outcomes—far beyond the long-standing 1:2 rule embedded in global exercise guidelines. Timestamps: (00:00) Introduction (07:01) What exactly is the 1:2 rule for exercise intensity? (08:18) Calorie burn vs. longevity—origins of the 1:2 rule (11:15) What counts as 'vigorous' exercise, really? (13:35) Where the exercise guidelines fall short (14:19) Can your wearable predict disease risk years in advance? (20:11) Is vigorous activity easier to achieve than people think? (22:47) How researchers avoided the 'healthy user bias' (23:59) Health equivalence ratio—a better way to measure exercise benefits? (25:45) Is vigorous exercise truly 4–10x more effective? (29:55) Can one vigorous minute match an hour of gentle walking? (32:02) Why vigorous activity—not gentle—offers dose-dependent benefits (33:50) Is vigorous exercise 5x better at preventing heart attacks & strokes? (34:24) Why vigorous activity stands out for cancer prevention (34:59) Does zone 2 qualify as vigorous exercise? (36:11) Dose-response comparison—vigorous vs. moderate vs. light activity (37:22) Is vigorous exercise the secret to younger arteries? (43:15) Why aging hearts need intensity (46:09) Can vigorous exercise halt your VO₂ max decline? (47:26) Why moderate exercise alone might not improve VO₂ max (49:21) Is vigorous exercise 10x more powerful at preventing diabetes? (55:48) Mitochondrial biogenesis—why intensity is essential (58:40) Can you directly measure mitochondrial health? (1:00:57) Does vigorous exercise kill circulating tumor cells? (1:07:15) Why vigorous intensity triggers beneficial hormone changes (1:08:05) Can vigorous activity protect older adults from falls? (1:12:36) Does vigorous exercise combat inflammation? (1:14:29) Is high-intensity training the key to a younger brain? (1:16:01) Is vigorous exercise more powerful than we realized? (1:17:50) Can the benefits of vigorous exercise fit into a pill? (1:19:08) How small doses of intensity might extend your lifespan (1:23:15) Do short bursts of vigorous movement match full workouts? (1:27:26) Why your wearable might undervalue short vigorous bouts (1:30:06) Can planned micro-workouts replace traditional gym sessions? (1:35:10) Why exercise guidelines urgently need updating (1:46:35) Does light activity still offer real benefits? (1:49:04) Is vigorous exercise safe for older adults? (1:53:28) Are high-intensity workouts detrimental to female hormones? (1:58:02) Safe vigorous exercise options—even with chronic illness (1:59:05) The 80/20 rule for balancing intensity and recovery (2:01:30) Inside Brady's routine—how much vigorous exercise is optimal? (2:05:17) Can vigorous activity boost kids' brainpower (and grades)? (2:08:14) Are we significantly underestimating vigorous exercise benefits? (2:10:03) Why chasing steps isn't the answer Show notes are available by clicking here Watch this episode on YouTube

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Bradley Calobrace, MD, discuss the following articles from the December 2025 issue: "Single-Dose versus 24-Hour Antibiotic Prophylaxis in Reduction Mammaplasty: A Randomized Controlled Trial" by Veiga, Garcia, Veiga-Filho, et al. Read the article for FREE: https://bit.ly/SingleDose24 Special guest, Dr. Calobrace is a nationally recognized plastic surgeon, an accomplished researcher, and a trusted educator whose work has shaped best practices in breast surgery and aesthetic medicine. Dr. Calobrace is a graduate of Indiana University Medical School and completed residencies in both general surgery and plastic surgery at the University of Southern California in Los Angeles. Subsequently, he completed a cosmetic and breast surgery fellowship with Dr. Pat Maxwell and began practice in Louisville, Kentucky. Although most known for aesthetic breast surgery nationally and internationally, Dr. Calobrace has a thriving aesthetic practice and fellowship in aesthetic surgery comprising an equal mix of breast, body, and facial aesthetic surgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCDec25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. FDA change in Boxed Warning Label for Hormone Replacement Therapy.  Discussion by:Guest:Anupriya Grover Wenk, DOFaculty - Family Medicine Residency ProgramJefferson Health - Abington2. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke – The New England Journal of Medicine 2025. Discussion by:Guest:Neil Skolnik, MD Professor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington3. AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program – JAMA. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. Incremental effect of healthy lifestyle habits when taking GLP-1 RA medications on Cardiac Risk Reduction.  Discussion by:Guest:Joe Gonella, MDResident– Family Medicine Residency ProgramJefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Episode 4 of our monthly GU Cast Journal Club and today we focus on two important papers in prostate cancer diagnostics and bladder cancer surgery. The PRECISION NEJM paper 2018 is a landmark publication which defined the role of mpMRI in early detection, and changed practice in many countries. The EB-StaR trial should also change practice after its European Urology 2024 publication, but has it??!We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. A very lively discussion!! Links to papers below:1. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis NEJM 20182. Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial Eur Urol 2024GU Cast Journal Club is supported by our Partner, MSD, through an unrestricted educational grant.Even better on our YouTube channelAbout GU Cast Journal Club:Each month, two papers are discussed, each of which are of importance to the GU Oncology community. These may be recent papers, or occasionally we will chose a classic landmark paper in GU Oncology. The objective is to draw attention to important papers in GU Oncology, and critique these in a robust manner. The key target audience is trainees working in Urology, Medical Oncology, Radiation Oncology, Nuclear Medicine, and diagnostic specialties such as Radiology and Pathology. But any of our regular audience are likely to enjoy this Journal Club series.

We come to you a bit lost, as one week rolls into another, and Christmas is almost here! But we made it, and are here to chat to you about how we are wrapping up the term for our families PLUS how seasonal homeschooling is helping us realign our days.Reports are a hot topic for both of us with January reporting due soon. Gulp!In exciting news, the Sisters Who Homeschool Patreon platform is open from today as we slowly begin the prologue of our Journal Club. And, what a beautiful time of year to rest and reflect.We explain the different ways you can join our Journal Club and give you a sneak peek into what will be on offer for our homeschooling community. Please follow the link in our show notes to become part of our Journal Club where we will share and celebrate all the unique experiences of homeschool life.Support the showThanks for listening! Purchase our Journal Kits here Journal Kits Join our Journal Club via our Patreon platform here Journal Club We would love to answer your questions and help you share your stories.Write to us at:hello.sisterswhohomeschool@gmail.comFollow us at:FacebookInstagram

Auch diesen Monat haben wir wieder eine spannende und unterhaltsame Folge für euch! Wir besprechen 3 große aktuelle intensivmedizinische Studien, die auf dem diesjährigen ESCIM-Jahreskongress vorgestellt wurden, diskutieren über das neue Curriculum für die Notärzt:innen in der Luftrettung und über einen neuen spannenden und sehr alltäglichen Lieblingsfehler. Und wir haben wieder Mark Weinert zu Gast, der uns sein neues Buch […] Der Beitrag Hauptfolge November 2025 – Folge 83 erschien zuerst auf pin-up-docs - don't panic.

ASOPRS Website: Click Here Join our host, Dr. Edith Reshef and esteemed guests Dr. Jonathan Lu, Dr. Seanna Grob, and Dr. Reza Vagefi in their discussion of the September-October issue of OPRS. Topics include utilization of serologic inflammatory markers in predicting orbital cellulitis severity, whether silicone cream is beneficial post-operatively for periorbital surgery, and management of refractive blepharospasm with partial orbicularis myectomy. Listen in to gain insight from our experts!

Send us a textBem-vindos ao episódio 67 de A Incubadora, o seu podcast quinzenal dedicado a democratizar o conhecimento em neonatologia e aproximar profissionais de saúde das melhores evidências científicas disponíveis. Aqui, discutimos de forma clara, crítica e contextualizada os avanços mais recentes da literatura, sempre com foco na prática clínica das UTIs neonatais brasileiras.No episódio de hoje, trazemos quatro artigos que dialogam com temas centrais da assistência ao recém-nascido de alto risco. Começamos explorando uma revisão de escopo publicada no Journal of Perinatology, que analisa o uso da ultrassonografia durante a reanimação neonatal — o NeoSONAR — e descreve como essa tecnologia pode transformar nossa abordagem nos primeiros minutos de vida. https://www.nature.com/articles/s41372-025-02458-zSeguimos com um estudo do Pediatric Research, que investiga o impacto do uso de leite humano doado no desenvolvimento estrutural do cérebro de prematuros muito pequenos, ampliando a discussão sobre nutrição, equidade e neuroproteção. https://www.nature.com/articles/s41390-025-04539-3No terceiro bloco, discutimos um artigo do Journal of Pediatrics que pergunta se é possível otimizar o rastreio da retinopatia da prematuridade através da combinação de escores de risco, reduzindo exames sem comprometer a segurança. https://www.jpeds.com/article/S0022-3476(25)00084-8/abstractE encerramos com uma publicação recente do Acta Paediatrica sobre estratégias para apoiar o contato pele a pele precoce em bebês nascidos entre 22 e 23 semanas — um tema que desafia paradigmas e reforça o potencial transformador do cuidado centrado na família, mesmo nos limites da viabilidade. https://onlinelibrary.wiley.com/doi/10.1111/apa.70255Fique com a gente para mais uma rodada de evidências atualizadas, interpretações cuidadosas e reflexões aplicadas ao nosso cotidiano nas UTIs neonatais. Não esqueça: você pode ter acesso aos artigos do nosso Journal Club no nosso site: https://www.the-incubator.org/podcast-1 Lembrando que o Podcast está no Instagram, @incubadora.podcast, onde a gente posta as figuras e tabelas de alguns artigos. Se estiver gostando do nosso Podcast, por favor dedique um pouquinho do seu tempo para deixar sua avaliação no seu aplicativo favorito e compartilhe com seus colegas. Isso é importante para a gente poder continuar produzindo os episódios. O nosso objetivo é democratizar a informação. Se quiser entrar em contato, nos mandar sugestões, comentários, críticas e elogios, manda um e-mail pra gente: incubadora@the-incubator.org

Today we break down a hard topic - how to navigate when people are negative towards your decision to homeschool.We share our experiences as first-generation homeschoolers, exploring why we think this is a common occurrence for homeschoolers - whether from a stranger at the shops or a close family member.We are here to help you handle these hard moments and protect your own energy when advocating for your child and family. We want to support you as your move forward through these conversations and learn to pick your battles. Sometimes agreeing to disagree may be the only option. Surrounding yourself with the right people who grow with you and listen to learn, will make all the difference on your homeschool journey.Support the showThanks for listening! Purchase our Journal Kits here Journal Kits Join our Journal Club via our Patreon platform here Journal Club We would love to answer your questions and help you share your stories.Write to us at:hello.sisterswhohomeschool@gmail.comFollow us at:FacebookInstagram

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Gabriel Del Corral, MD, discuss the following articles from the November 2025 issue: "Venous Thromboembolism Chemoprophylaxis in Plastic Surgery: A Randomized Controlled Trial of Apixaban versus Enoxaparin" by Momeni, Yesantharao, Meyer, et al. Read the article for FREE: https://bit.ly/ApixVSEnoxRCT Special guest, Dr. Gabriel Del Corral is a Professor of Plastic Surgery at MedStar Georgetown University Hospital and the Director of the MedStar Center for Gender Affirmation. He completed his general surgery residency at Main Line Health Jefferson Health System, followed by his plastic surgery residency at Vanderbilt University Medical Center. He then completed a microsurgery fellowship at the University of Pennsylvania. He specializes in both breast reconstruction, as well as head-to-toe and comprehensive gender affirming operations, including facial surgery, top surgery and bottom surgery, and is widely published in all areas of gender affirmation. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCNov25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Caudal Epidural Steroid Injection with PRP Case Reports and a Testimonial! Upcoming Training Courses and Services Regional Anesthesia and IV Vascular Access Courses: New York and Detroit locations scheduled Pain Management Board Preparation   Private Coaching Services: Ultrasound guidance Preceptorship Board preparation coaching Contact available via email Info@NRAPpain.org for interested physicians PRP Caudal Epidural Research Review Study Overview: Randomized double-blind controlled pilot study comparing leukocyte-rich PRP versus corticosteroids in caudal epidural space 50 patients randomly assigned to two groups Treatment options: triamcinolone 60mg or leukocyte-rich PRP from 60ml autologous blood Follow-up assessments at 1, 3, and 6 months using VAS and SF-36 surveys Key Findings: Both treatments showed significant pain reduction compared to baseline Steroid group had lower VAS scores at one month PRP group demonstrated superior results at 3 and 6 months PRP group showed significant improvement across all SF-36 domains at 6 months No complications or adverse effects in either group during 6-month follow-up Personal Treatment Experience Dr. Rosenblum received transforaminal PRP injection 9-10 weeks ago Gradual improvement noted from weeks 4-8, with more noticeable benefits from weeks 8-10 Current status: minimal pain (0.5/10) only during weather changes Clinical Practice Philosophy Treatment Approach: Minimalist philosophy focusing on turmeric, PRP, and Pilates Medication Strategy: Low-dose naltrexone as go-to medication, avoiding long-term drugs with side effects Surgical Avoidance: Prioritizing conservative treatments over unnecessary surgical interventions Emergency Department PRP Implementation Case Study Results: Ultrasound-guided caudal epidural steroid injection in ER setting 100% pain resolution achieved Patient discharged directly from ER Cost savings: reduced from $33,000 to $4,800 (approximately $28,000 savings) Training Opportunities: Private training sessions available for ER physicians interested in ultrasound-guided procedures Patient Testimonial Highlights Case Background: Nurse with herniated disc from March, previously considering $30,000 surgery Treatment Outcome: PRP injection completed two months ago with nearly complete pain relief Reduced from multiple pain medications to one Advil daily Eliminated antalgic posture and muscle spasms Returned to full 12-hour hospital shifts without difficulty Overall quality of life restored to normal levels David Rosenblum, MD, currently serves as the Director of Pain Management at Maimonides Medical Center and AABP Integrative Pain Care.  As a member of the Department of Anesthesiology, he is involved in teaching, research, CME activities, and was key faculty in developing the anesthesiology residency's regional anesthesia block rotation, as well as institutional wide acute and chronic pain management protocols to ensure safe and effective pain management. He currently is a managing partner in a multi-physician private pain practice, AABP Integrative Pain Care, located in Brooklyn, NY. He is one of the earliest interventional pain physicians to integrate ultrasound guidance to improve the safety and accuracy of interventional pain procedures.   Awards New York Magazine: Top Doctors: 2016, 2017, 2018, 2021, 2022, 2023, 2024, 2025 Schneps Media: 2015, 2016, 2017, 2019, 2020 Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 2025 Schneps Media - Brooklyn Courier Life: 2021, 2022, 2023   Dr. Rosenblum written several book chapters on Peripheral Neuromodulation, Radiofrequency Ablation, and Pharmacology.  He has published numerous noteworthy articles and most recently is developing the ASIPP Guidelines for Peripheral Neuromodulation in the treatment of chronic pain. He has been named several times in NY Magazine's Best Pain Management Doctor List, Nassau County's Best Pain Physician, has appeared on NY1 News, and has made several appearances on XM Radio's Doctor Talk. He currently is lecturing on a national and international level and has partnered with the American Society of Interventional Pain Physicians (ASIPP), American Society of Pain and Neuroscience (ASPN), IASP Mexican Chapter, Eastern Pain Association (EPA), the North American Neuromodulation Society (NANS), World Academy of Pain Medicine United, as well as various other organizations, to support educational events and develop new courses. Since 2008, he has helped over 3000 physicians pass the Pain Management Boards, and has been at the forefront of utilizing ultrasound guidance to perform pain procedures.  He now hosts the PainExam podcast, AnesthesiaExam Podcast, PMRExam Podcasts and uses this platform to promote the safe and effective use of ultrasound in the performance of various procedures such as Peripheral Nerve Stimulation, Caudal Epidurals, Selective Nerve Root Blocks, Cluneal Nerve Blocks, Ganglion impar Blocks, Stellate Ganglion Blocks, Brachial Plexus Blocks, Joint Injections and much more!   Doctor Rosenblum created the NRAP (Neuromodulation Regional Anesthesia and Pain) Academy  and travels to teach various courses focused on Pain Medicine, Regenerative Medicine, Ultrasound Guided Pain Procedures and Regional Anesthesia Techniques.    Dr. Rosenblum is persistent when it comes to eliminating pain and has gained a reputation among his patients for thinking "outside the box" and implements ultrasound guidance to deposit medications, biologics (PRP, Bone Marrow Aspirate, etc.) and Peripheral Nerve Stimulators near pain generators. He is currently treating patients in his great neck and Brooklyn office.  For an appointment go to AABPpain.com or call Brooklyn     718 436 7246 Reference Irvan J. Bubic, Jessica Oswald, Ultrasound-Guided Caudal Epidural Steroid Injection for Back Pain: A Case Report of Successful Emergency Department Management of Radicular Low Back Pain Symptoms, The Journal of Emergency Medicine,Volume 61, Issue 3,2021,Pages 293-297,ISSN 0736-4679 Ruiz‐Lopez, Ricardo, and Yu‐Chuan Tsai. "A randomized double‐blind controlled pilot study comparing leucocyte‐rich platelet‐rich plasma and corticosteroid in caudal epidural injection for complex chronic degenerative spinal pain." Pain Practice 20.6 (2020): 639-646. #prppain #paincme #sciatia #ultrasoundmsk #ultrasoundprp #epidural #nypaindoctor #prppainwindsor

‍ ‍Drs. Akshay Thomas and Sarwar Zahid join for a journal club episode discussion of three recent publications:‍ ‍ ‍ ‍Fellow Eye PVD (https://journals.sagepub.com/doi/full/10.1177/24741264251379842)‍ ‍Syfovre versus Izervay (https://journals.sagepub.com/doi/full/10.1177/24741264251379842)‍ ‍Litigation Involving Intravitreal Injections (https://www.ophthalmologyretina.org/article/S2468-6530(25)00439-7/abstract)‍ ‍ ‍ ‍Disclosures: Dr. Sridhar has consulted for Apellis and Astellas in the past 3 years. ‍ ‍

Join us for the November edition of the Simulcast Journal Club, hosted by Vic Brazil and Ben Symon. In this episode: Sense of presence in sim, connecting human factors and translational simulation, positive deviants in in situ simulation and students portraying patients in simulation. And some serious stats… :-)  The November papers  Chevalier S, et al. ‘It feels like I was there!' A cross-sectional study to understand the sense of presence in simulation, the role of internal factors and simulation modalities.  J Healthc Simul. 2025; https://doi.org/10.54531/QUXY5470  O'Connor P, Byrne D, O'Dea A. Human factors and translational simulation: misunderstandings and potential opportunities. J Healthc Simul. 2025; Published 2 Oct 2025. https://doi.org/10.54531/UYWH1164  Baril L, et al. Uncovering success stories: how to resuscitate in situ simulation initiatives in Canadian emergency departments. Adv Simul. 2025;10:47. https://doi.org/10.1186/s41077-025-00376-w  Dalwood, N., et al.  ‘Acting it out really makes it stick in your brain': Educating students for patient portrayal during peer simulation. Medical Teacher, 2025. 1–15. https://doi.org/10.1080/0142159X.2025.2570820  Another great month on Simulcast.  Happy listening    

Join us for this month's Journal Club from the Prehospital Care Research Forum as we take a closer look at the NAEMSP Trauma Compendium: a landmark collection of trauma care guidance from some of the field's leading voices. In this special episode, we're joined by the lead author for a guided tour through each article, while our panelists bring sharp questions and on-the-ground insights. Whether you're in the classroom or on the curbside, this is the trauma update you don't want to miss.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Gabriel Del Corral, MD, discuss the following articles from the November 2025 issue: "Learning Curve for Sensory Preservation after Transgender Mastectomy Using Targeted Nipple-Areola Complex Reinnervation with Direct Nerve Coaptation" by Alston, Remy, Kochheiser, et al. Read the article for FREE: https://bit.ly/TNRCurve Special guest, Dr. Gabriel Del Corral is a Professor of Plastic Surgery at MedStar Georgetown University Hospital and the Director of the MedStar Center for Gender Affirmation. He completed his general surgery residency at Main Line Health Jefferson Health System, followed by his plastic surgery residency at Vanderbilt University Medical Center. He then completed a microsurgery fellowship at the University of Pennsylvania. He specializes in both breast reconstruction, as well as head-to-toe and comprehensive gender affirming operations, including facial surgery, top surgery and bottom surgery, and is widely published in all areas of gender affirmation. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCNov25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publications here.

Send us a textNeste episódio duplamente especial do podcast A Incubadora, Mariana Oliveira e Marola discutem as novas diretrizes de reanimação neonatal publicadas em outubro de 2025. Elas destacam a importância do Dia Mundial da Prematuridade e a necessidade de conscientização sobre os cuidados neonatais. O slogan da Campanha, “Garanta aos prematuros começos saudáveis para futuros brilhantes”, vem de encontro ao momento mais especial da Neonatologia: o nascimento. As novas diretrizes introduzem o conceito da cadeia de cuidado do recém-nascido, que abrange desde o pré-natal até o acompanhamento pós-alta. O episódio detalha as etapas de reanimação, a importância da ventilação, o manejo do cordão umbilical e os cuidados pós-reanimação, além de enfatizar a necessidade de treinamento contínuo das equipes de saúde e a humanização do atendimento.Confira o documento na íntegra aqui: https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000001367neonatologia, reanimação neonatal, prematuridade, diretrizes, cuidados neonatais, saúde materna, ventilação, cordão umbilical, treinamento, ética Não esqueça: você pode ter acesso aos artigos do nosso Journal Club no nosso site: https://www.the-incubator.org/podcast-1 Lembrando que o Podcast está no Instagram, @incubadora.podcast, onde a gente posta as figuras e tabelas de alguns artigos. Se estiver gostando do nosso Podcast, por favor dedique um pouquinho do seu tempo para deixar sua avaliação no seu aplicativo favorito e compartilhe com seus colegas. Isso é importante para a gente poder continuar produzindo os episódios. O nosso objetivo é democratizar a informação. Se quiser entrar em contato, nos mandar sugestões, comentários, críticas e elogios, manda um e-mail pra gente: incubadora@the-incubator.org

Featuring an interview with Dr Aaron Lisberg, including the following topics: Prevention and Management of Adverse Events of Special Interest with Datopotamab Deruxtecan (Dato-DXd) (0:00) Rugo H et al. US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan. Support Care Cancer 2025;33(9):756. Abstract Lisberg A et al. Datopotamab deruxtecan-associated select adverse events: Clinical practices and institutional protocols on prophylaxis, monitoring, and management. Oncologist 2025;[Online ahead of print]. Abstract Meric-Bernstam F et al. Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis. Oncologist 2025;30(3). Abstract Novel Strategies Combining Dato-DXd with Osimertinib (10:44) Lu S et al. TROPION-Lung14: A phase 3 study of osimertinib ± datopotamab deruxtecan (Dato-DXd) as first-line (1L) treatment for patients with EGFR-mutated locally advanced or metastatic (LA/M) non-small cell lung cancer (NSCLC). ASCO 2025;Abstract TPS8647. Nadal E et al. TROPION-Lung15: A phase III study of datopotamab deruxtecan (Dato-DXd) ± osimertinib vs platinum doublet chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) and disease progression on prior osimertinib. ELCC 2025;Abstract 124TiP. Intracranial Activity Observed with TROP2-Targeting Antibody-Drug Conjugates (15:14) Felip E et al. Brain metastases and actionable genetic alterations with sacituzumab govitecan versus docetaxel in metastatic non-small cell lung cancer: Subgroups of the phase III EVOKE-01 trial. ELCC 2025;Abstract 13P. Lisberg A et al. Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05. ASCO 2024;Abstract 8593. Pons-Tostivint E et al. Intracranial efficacy of datopotamab deruxtecan (Dato- DXd) in patients with advanced/metastatic NSCLC in TROPION-Lung01. WCLC 2025;Abstract OA10.01. CME information and select publications

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Gabriel Del Corral, MD, discuss the following articles from the November 2025 issue: "The External Strip and Internal Spreader Graft Combined with Dorsal Preservation Rhinoplasty" by Öztürk. Read the article for FREE: https://bit.ly/ExtRhinoSpreader Special guest, Dr. Gabriel Del Corral is a Professor of Plastic Surgery at MedStar Georgetown University Hospital and the Director of the MedStar Center for Gender Affirmation. He completed his general surgery residency at Main Line Health Jefferson Health System, followed by his plastic surgery residency at Vanderbilt University Medical Center. He then completed a microsurgery fellowship at the University of Pennsylvania. He specializes in both breast reconstruction, as well as head-to-toe and comprehensive gender affirming operations, including facial surgery, top surgery and bottom surgery, and is widely published in all areas of gender affirmation. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCNov25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Send us a textWelcome to The Oncology Journal Club Podcast Series 3Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology NetworkKate Clarke takes over hosting duties!Join our expert trio — Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson — for the usual OJC antics in Part 2 of our ESMO Special.Craig talks us through the GU and lung highlights, while the team each share their top ‘practice-changing' abstracts. Plus, CJ chats with Susie Stanway about the upcoming London Global Cancer Week.Expect nuanced analysis, sharp insights and the occasional cheeky joke along the way.To learn more about The Oncology Network, subscribe to our free weekly Newsletter and listen to other fantastic podcasts, visit our website: www.oncologynetwork.com.au. You'll also find the Show Notes on the website with links to the abstracts, bios of our hosts and a downloadable Bingo Card

In this episode, Dr's J and Santhosh once again perform their biweekly roundup of whats new in the medical world, this time with an emphasis on feel good research. Along the way they cover the intersection of Les Mis and the muppets, fat bear week, ozempic effects on imaging studies, xenotransplantation of the first pig liver, gene manipulation, full metal alchemist, innies v outies, the belly button biodiversity project, greek mythology, peripheral immunity and the nobel prize, the 2025 Ignoble award winners, and more! so sit back and relax as we teach you whats new in medical research!Further Readinghttps://www.researchsquare.com/article/rs-7514267/v1https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0329983https://www.eurekalert.org/news-releases/1100522https://linkinghub.elsevier.com/retrieve/pii/S0168827825024973Support Us spiritually, emotionally or financially here! or on ACAST+travelmedicinepodcast.comBlueSky/Mastodon/X: @doctorjcomedy @toshyfroTikotok: DrjtoksmedicineGmail: travelmedicinepodcast@gmail.comSpotify: https://open.spotify.com/show/28uQe3cYGrTLhP6X0zyEhTPatreon: https://www.patreon.com/travelmedicinepodcast Hosted on Acast. See acast.com/privacy for more information.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Step Accumulation Patterns and Risk for Cardiovascular Events andMortality Among Suboptimally Active Adults – Annals of Internal Medicine 2025.  Discussion by:Guest:Kathryn Donnelly, DO Resident - Family Medicine Residency ProgramJefferson Health - Abington2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Obesity – The New England Journal of Medicine 2025. Discussion by:Guest:Ajay Rau, MDChief - Section of Endocrinology, Diabetes and Metabolism Lewis Katz School of Medicine at Temple University3. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. New England Journal Of Medicine 2025.  Discussion by: Guest:Jasmin Walker, MD Resident – Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Dr. Jeanne De Lavallaz and Dr. Ramy Doss discuss the results of the  TRANSFORM-AF Trial with expert faculty Dr. Sanjeev Saksena and Dr. Varun Sundaram.   The TRANSFORM-AF trial enrolled 2,510 patients with atrial fibrillation (AF), type 2 diabetes, and obesity across 170 Veterans Affairs hospitals to evaluate the impact of diabetes-dose GLP-1 receptor agonists on AF-related outcomes. Participants were assigned to receive either a GLP-1 receptor agonist, a DPP-IV inhibitor, or a sulfonylurea. The primary composite outcome included AF-related hospitalizations, cardioversions, ablation procedures, and all-cause mortality. Over a median follow-up of 3.2 years, GLP-1 use was associated with a 13% reduction in major AF-related events compared to other therapies. The study population was predominantly male, with a high prevalence of severe obesity (BMI >40 kg/m²) in whom the benefit appeared most pronounced. Notably, the observed benefit occurred despite only modest additional weight loss, suggesting potential non-weight-mediated effects of GLP-1 therapy  This episode was planned in collaboration with  Heart Rhythm TV with mentorship from Dr. Daniel Alyesh and Dr. Mehak Dhande.  CardioNerds Journal Club PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!

In this special bonus episode of the Award-winning PRS Journal Club Podcast, recorded live at PSTM 2025 in New Orleans, LA, Dr. Brett Phillips discusses the topic "Reanimation for Moebius Syndrome." This session was moderated by the 2025 Resident Ambassadors – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter. Read the discussed article: https://bit.ly/MoebFacialReanimation READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCOct25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Recurrent urinary tract infections (UTIs) are a common challenge for people with spinal cord injury, but new research shows that many suspected cases aren't true infections. In this episode, Madison Hughes and Dr. Chris Elliott discuss how recurrent UTIs are diagnosed and managed in the spinal cord injury population, the role of urodynamics and bladder diaries, and why patient education and non-antibiotic strategies can make such a big difference. 

Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer. CME information and select publications here.

Send us a textAzithromycin for Prevention of Bronchopulmonary Dysplasia and Other Neonatal Adverse Outcomes in Preterm Infants: An Updated Systematic Review and Meta-Analysis.Joseph M, Murali Krishna M, Karlinksi Vizentin V, Provinciatto H, Ezenna C.Neonatology. 2025 Aug 12:1-10. doi: 10.1159/000547537. Online ahead of print.PMID: 40795809 Free article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textInfant Renal Replacement Therapy Using Carpediem™: A Multicenter Observational Cohort Study from the ICONIIC Learning Network.Slagle CL, Vuong KT, Krallman KA, Casey L, Gist KM, Jetton JG, Joseph C, Luckritz K, Martin SD, Morgan J, Merrill KA, Plomaritas K, Ramirez D, Tran CL, Shin HS, Snyder AN, Van Wyk B, Yalon L, Goldstein SL, Menon S.J Pediatr. 2025 Sep 26:114838. doi: 10.1016/j.jpeds.2025.114838. Online ahead of print.PMID: 41016463 Free article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textRisk factors associated with the development of necrotizing enterocolitis in preterm infants on an exclusive human milk diet: a single-center case-control study.Ailumerab H, Miller JL, DeShea L, Beasley WH, Chaaban H, Bergner EM.J Perinatol. 2025 Aug 30. doi: 10.1038/s41372-025-02401-2. Online ahead of print.PMID: 40885806Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textIdentifying optimal positive end-expiratory pressure with electrical impedance tomography guidance in severe bronchopulmonary dysplasia.Shui JE, LaVita CJ, Alcala GC, Nichols JH, Jassar RK, Turcu RM, Lerou PH, Cereda MF, Carroll RW, Ribeiro De Santis Santiago R, Berra L.J Perinatol. 2025 Sep 30. doi: 10.1038/s41372-025-02433-8. Online ahead of print.PMID: 41028823Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textNebulized nitroglycerin as an adjuvant drug in management of persistent pulmonary hypertension of newborns: a randomized controlled trial.Farag MM, Ghazal HAE, Abdel-Mohsen AM, Rezk MA.Eur J Pediatr. 2025 Sep 1;184(9):586. doi: 10.1007/s00431-025-06381-5.PMID: 40888971 Free PMC article. Clinical Trial.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textShort-term and long-term effects of vitamin D supplementation for preterm infants: a systematic review and meta-analysis.Shin SH, Kim HJ, Heo JS.J Perinatol. 2025 Oct 7. doi: 10.1038/s41372-025-02440-9. Online ahead of print.PMID: 41057557Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textWhat's new in neonatal innovation and research this week?Join Ben and Daphna for a lively Journal Club episode of The Incubator Podcast, recorded after a long NICU day but packed with energy and insight. They begin with an update on the newly released NRP 9th Edition, preview their excitement for the upcoming Delphi Neonatal Innovation Conference, and then dive into five remarkable studies shaping neonatal care.From the use of CARPEDIEM for renal replacement therapy in the tiniest infants to a meta-analysis on high-dose vitamin D supplementation, the hosts explore how evolving evidence can transform bedside care. They examine a novel trial of nebulized nitroglycerin for PPHN, the role of electrical impedance tomography (EIT) in optimizing PEEP for infants with severe BPD, and new insights into NEC risk factors even among exclusively human-milk-fed babies.With their trademark mix of curiosity, humor, and critical reflection, Ben and Daphna make complex studies both understandable and relevant for everyday NICU practice.Stay informed and inspired—listen now, and explore more neonatal research and conference updates at www.the-incubator.org. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textNeste episódio, mergulhamos em quatro estudos recentes que trazem novas perspectivas para a prática em neonatologia. Discutimos um protocolo universal padronizado para o uso de ultrassonografia abdominal no diagnóstico de enterocolite necrosante, a comparação entre a ultrassonografia craniana realizada na 6ª semana de vida e na idade equivalente ao termo em prematuros de alto risco, o ensaio clínico FEED1, que investiga os efeitos de iniciar a alimentação enteral plena desde o primeiro dia de vida, e uma revisão sistemática sobre o rastreamento de autismo em crianças nascidas prematuras.Os artigos apresentados são: 1) A standardized universal protocol for using adjunct abdominal ultrasound at the time of diagnosis for suspected necrotizing enterocolitis. https://link.springer.com/article/10.1007/s00247-025-06408-x2) Cranial Ultrasound at 6 Weeks Postnatal Age Versus Term Equivalent Age in High-risk Pre-term Infants: A Prospective Cohort Study. https://www.umbjournal.org/article/S0301-5629(25)00379-5/fulltext3) Full exclusively enteral fluids from day 1 versus gradual feeding in preterm infants (FEED1): a open-label, parallel-group, multicentre, randomised, superiority trial. https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(25)00271-8/fulltext4) Screening for Autism in Preterm Children: A Systematic Review. https://pubmed.ncbi.nlm.nih.gov/40897396/A Incubadora é um podcast quinzenal que tem como objetivo democratizar o conhecimento em neonatologia, ampliando o acesso às melhores evidências científicas. Não esqueça: você pode ter acesso aos artigos do nosso Journal Club no nosso site: https://www.the-incubator.org/podcast-1 Lembrando que o Podcast está no Instagram, @incubadora.podcast, onde a gente posta as figuras e tabelas de alguns artigos. Se estiver gostando do nosso Podcast, por favor dedique um pouquinho do seu tempo para deixar sua avaliação no seu aplicativo favorito e compartilhe com seus colegas. Isso é importante para a gente poder continuar produzindo os episódios. O nosso objetivo é democratizar a informação. Se quiser entrar em contato, nos mandar sugestões, comentários, críticas e elogios, manda um e-mail pra gente: incubadora@the-incubator.org

The latest podcast with DR Justin Morgenstern. We look at all the latest evidence and a few older pieces from the world of Emergency care. this month we tackle: AI bots for OMIs, paracentesis plumbing, antiplatelet pharma, facial fractures and a sublingual anaphylaxis agent!  Its a lot!  #FOAMed

Featuring an interview with Dr Kevin Kalinsky, including the following topics: Prophylaxis, Monitoring and Management of Adverse Events of Special Interest with Datopotamab Deruxtecan (0:00) Lisberg A et al. Datopotamab deruxtecan-associated select adverse events: Clinical practices and institutional protocols on prophylaxis, monitoring, and management. Oncologist 2025;30(9). Abstract  Meric-Bernstam F et al. Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis. Oncologist 2025;30(3). Abstract   Clinical Data with Neoadjuvant Datopotamab Deruxtecan from the I-SPY 2.2 Phase II Trial (5:17) Khoury K et al. Datopotamab–deruxtecan in early-stage breast cancer: The sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med 2024;30(12):3728-36. Abstract  Shatsky RA et al. Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: The sequential multiple assignment randomized I-SPY2.2 Phase II trial. Nat Med 2024;30(12):3737-47. Abstract  NeoSTAR: A Phase II Study of Response-Guided Neoadjuvant Sacituzumab Govitecan and Pembrolizumab for Localized Triple-Negative Breast Cancer (9:09) Abelman RO et al. A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. ASCO 2025;Abstract 511.  OptimICE-RD: A Phase III Study Evaluating Sacituzumab Govitecan with Pembrolizumab versus Pembrolizumab with or without Capecitabine for Residual Triple-Negative Breast Cancer (12:56) Tolaney SM et al. OptimICE-RD: Sacituzumab govitecan + pembrolizumab vs pembrolizumab (± capecitabine) for residual triple-negative breast cancer. Future Oncol 2024;20(31):2343-55. Abstract  CME information and select publications

Drs. Priya Vakharia and Sarwar Zahid join for a journal club discussion. Functional Benefit in Geographic Atrophy Treatment (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2839343) GLP-1 Agonists and Uveitis (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2838119) Metformin and AMD (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2838821)

Featuring an interview with Dr Aaron Lisberg, including the following topics: Efficacy and Safety of Datopotamab Deruxtecan (Dato-DXd) for Patients with Previously Treated EGFR-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC): A Pooled Analysis of the TROPION-Lung01 and TROPION-Lung05 Trials (0:00) Ahn M-J et al. Efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously-treated EGFR-mutated advanced non-small cell lung cancer (NSCLC): A pooled analysis of TROPION-Lung01 and TROPION-Lung05. ESMO Asia 2024;Abstract LBA7 Ahn M-J et al. A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC. J Thorac Oncol 2025;[Online ahead of print]. Abstract Sacituzumab Tirumotecan for Previously Treated Advanced EGFR-Mutated NSCLC: Results from the Randomized OptiTROP-Lung03 Study (7:08) Fang W et al. Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: Multicentre, open label, randomised controlled trial. BMJ 2025;389:e085680. Abstract Zhang L et al. Sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced EGFR-mutated non-small cell lung cancer (NSCLC): Results from the randomized OptiTROP-Lung03 study. ASCO 2025;Abstract 8507. Combination of Dato-DXd and Immunotherapy as First-Line Therapy for Patients with Advanced NSCLC (13:12) Cuppens K et al. First-line (1L) datopotamab deruxtecan (Dato-DXd) + durvalumab ± carboplatin in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohorts 2 and 4). ESMO Targeted Anticancer Therapies Congress 2025;Abstract 8O. Okamoto I et al. TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer. Future Oncol 2024;20(37):2927-36. Abstract Levy BP et al. TROPION-Lung08: Phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC. Future Oncol 2023;19(21):1461-72. Abstract Aggarwal C et al. AVANZAR: Phase III study of datopotamab deruxtecan (Dato-DXd) + durvalumab + carboplatin as 1L treatment of advanced/mNSCLC. World Conference on Lung Cancer (WCLC) 2023;Abstract P2.04-02. TROP2-Targeting Antibody-Drug Conjugates as Neoadjuvant and/or Adjuvant Therapy for Patients with Resectable NSCLC (19:08) A phase III, randomised, open-label, global study of adjuvant datopotamab deruxtecan (Dato-DXd) in combination with rilvegostomig or rilvegostomig monotherapy versus standard of care, following complete tumour resection, in participants with Stage I adenocarcinoma non-small cell lung cancer who are ctDNA-positive or have high-risk pathological features (TROPION-Lung12). NCT06564844 Cascone T et al. Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: The platform phase 2 NeoCOAST-2 trial. Nat Med 2025;31(8):2788-96. Abstract CME information and select publications

Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publications here.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, David Stepien, MD, discuss the following articles from the October 2025 issue: “Private Equity Investment in Plastic Surgery Clinics: A Scoping Review” by Roth, Yu, and Taub. Read the article for FREE: https://bit.ly/PSClinicInvest Special guest, David Stepien, MD, is currently an Assistant Professor of Plastic Surgery at Duke University, where he performs both aesthetic and reconstructive surgery focusing primarily on facial rejuvenation, rhinoplasty, and aesthetic breast surgery. He obtained his MD and his PhD from Boston University, followed by integrated plastic surgery residency at the University of Michigan and aesthetic surgery fellowship at The Aesthetic Surgery Fellowship of Los Angeles. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCOct25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Join us for the October edition of the Simulcast Journal Club, hosted by Vic Brazil and Ben Symon. In this episode: AI in simulation, simulation reducing sick leave, calculating the cost of simulation, and simulation based toolkits to address hospital acquired conditions.     The October papers   Cheng A, McGregor C. Applications of artificial intelligence in healthcare simulation: a model of thinking. Advances in Simulation. 2025;10:45. https://doi.org/10.1186/s41077-025-00379-7   Schram AL, Bonne NL, Henriksen TB, Hertel NT, Petersen PG, Bjerrum MC, et al. Effect of simulation-based team training on sick leave among healthcare professionals: a multisite controlled follow-up study. Journal of Healthcare Simulation. 2025 Sep 3. https://doi.org/10.54531/XCVT3140   Verhoeff TL, Janssen JJHM, Röell AE, Hoff RG. The surprising costs of on-site surgical team CRM training: a Dutch example analyzed. Advances in Simulation. 2025;10:37. https://doi.org/10.1186/s41077-025-00367-x   Barker LT, Bond WF, Willemsen-Dunlap AM, Cooley KL, McGarvey JS, Ruger RL, et al. Simulation-Debriefing Enhanced Needs Assessment to address quality markers in health care: an innovation for prospective hazard analysis. The Joint Commission Journal on Quality and Patient Safety. 2025;51:144–158. https://doi.org/10.1016/j.jcjq.2024.10.004     Another great month on Simulcast.  Happy listening 

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, David Stepien, MD, discuss the following articles from the October 2025 issue: “Deep Plane Face Lift in Asian Patients” by Wong, Hsieh, and Mendelson. Read the article for FREE: https://bit.ly/AsianDPFL Special guest, David Stepien, MD, is currently an Assistant Professor of Plastic Surgery at Duke University, where he performs both aesthetic and reconstructive surgery focusing primarily on facial rejuvenation, rhinoplasty, and aesthetic breast surgery. He obtained his MD and his PhD from Boston University, followed by integrated plastic surgery residency at the University of Michigan and aesthetic surgery fellowship at The Aesthetic Surgery Fellowship of Los Angeles. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCOct25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Send us a textScreening for Autism in Preterm Children: A Systematic Review.Thomas KE, Raghuram K, Banihani R, Church PT, Mbuagbaw L, Penner M.Pediatrics. 2025 Sep 3:e2024069837. doi: 10.1542/peds.2024-069837. Online ahead of print.PMID: 40897396Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textAntenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery: A Randomized Clinical Trial.Lee SM, Park HS, Choi SR, Lee J, Kim HJ, Park JY, Oh KJ, Cho GJ, Oh MJ, Chung JH, Kim SM, Kim BJ, Kim SY, Hong S, Jung YM, Lee SJ, Seong JS, Kim H, Oh S, Lee J, Jin YR, Kim JH, Cho HY, Park CW, Park JS, Jun JK.JAMA Pediatr. 2025 Sep 22:e253284. doi: 10.1001/jamapediatrics.2025.3284. Online ahead of print.PMID: 40982289Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textEffect of enteral supplementation of DHA with or without ARA in preterm infants: a meta-analysis.Dang D, Gao Z, Zhang C, Mu X, Lv X, Wu H.Arch Dis Child Fetal Neonatal Ed. 2025 Apr 15:fetalneonatal-2024-327606. doi: 10.1136/archdischild-2024-327606. Online ahead of print.PMID: 40233974Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textComparison of neurodevelopmental outcomes of extremely preterm infants undergoing trans-catheter closure of the patent ductus arteriosus compared to surgical ligation.Kaluarachchi DC, Chock VY, Do BT, Rysavy MA, Sankar MN, Laughon MM, Backes CH, Colaizy TT, Bell EF, McNamara PJ, Hintz SR, Natarajan G.J Perinatol. 2025 Sep 23. doi: 10.1038/s41372-025-02417-8. Online ahead of print.PMID: 40987835Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textParent and practitioner experiences of opt-out consent in neonatal intensive care: a mixed methods study within a trial.Mitchell T, Andrzejewska I, Battersby C, Cole C, Daskalopoulou Z, Dorling J, Gale C, Graham M, Hubbard M, Hardy P, Hurd M, King AR, Manley BJ, Murray D, Nuthall E, O'Connor H, Ojha S, Roberts CT, Rodriquez A, Roehr CC, Stanbury K, Tume L, Young L, Woolfall K.Arch Dis Child Fetal Neonatal Ed. 2025 Aug 31:fetalneonatal-2025-328693. doi: 10.1136/archdischild-2025-328693. Online ahead of print.PMID: 40889884Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textCritical Congenital Heart Disease and Infant Cancer.Chin S, Lupo PJ, Baer R, Hobbs CA, Chambers CD, Bandoli G.Pediatrics. 2025 Sep 25:e2025072934. doi: 10.1542/peds.2025-072934. Online ahead of print.PMID: 40992753 No abstract available.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textIn this Journal Club episode, Ben and Daphna review a wide range of new research shaping neonatal practice and policy.The discussion begins with a randomized controlled trial from Korea examining antenatal corticosteroid use in twin pregnancies at risk for late preterm delivery, showing reductions in neonatal respiratory morbidity. They then turn to a meta-analysis on DHA with or without ARA supplementation in preterm infants, where results raised concerns about potential increased risk of BPD, highlighting the need for more precise dosing and study design.A major feature of this episode is the release of the Improving Neonatology Staffing Toolkit, presented with guests Dr. Kerri Machut and Dr. Milenka Cuevas Guaman. They explain how the toolkit builds on consensus recommendations to offer practical guidance, case studies, and advocacy resources for units of all sizes.Ben and Daphna also review a multi-center study comparing transcatheter closure and surgical ligation of the PDA in extremely preterm infants, finding similar neurodevelopmental outcomes at 2 years. Additional topics include an analysis of opt-out consent in neonatal trials, new data on the association between critical congenital heart disease and infant cancer, and a systematic review of autism screening tools for preterm children.A dense episode full of data and practical implications for neonatology.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!